314 related articles for article (PubMed ID: 33956132)
1. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
Dubin JR; Simon SD; Norrell K; Perera J; Gowen J; Cil A
JAMA Netw Open; 2021 May; 4(5):e217274. PubMed ID: 33956132
[TBL] [Abstract][Full Text] [Related]
2. Analysis of FDA-Approved Orthopaedic Devices and Their Recalls.
Day CS; Park DJ; Rozenshteyn FS; Owusu-Sarpong N; Gonzalez A
J Bone Joint Surg Am; 2016 Mar; 98(6):517-24. PubMed ID: 26984921
[TBL] [Abstract][Full Text] [Related]
3. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
Samuel AM; Rathi VK; Grauer JN; Ross JS
Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
[TBL] [Abstract][Full Text] [Related]
4. Recalls of Moderate- and High-Risk Otolaryngologic Devices Approved by the US Food and Drug Administration, 2003-2019.
Talati IA; Parsa KM; Gao WZ
Otolaryngol Head Neck Surg; 2022 Nov; 167(5):832-838. PubMed ID: 35290135
[TBL] [Abstract][Full Text] [Related]
5. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
Peters W; Pellerin C; Janney C
Biomed Instrum Technol; 2020 Nov; 54(6):418-426. PubMed ID: 33339030
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Obstetric and Gynecologic Food and Drug Administration Device Approvals and Recalls.
Galhotra S; Maurice J
J Minim Invasive Gynecol; 2018; 25(7):1281-1288. PubMed ID: 29653261
[TBL] [Abstract][Full Text] [Related]
7. Risk of Recall Associated With Modifications to High-risk Medical Devices Approved Through US Food and Drug Administration Supplements.
Dubin JR; Enriquez JR; Cheng AL; Campbell H; Cil A
JAMA Netw Open; 2023 Apr; 6(4):e237699. PubMed ID: 37043202
[TBL] [Abstract][Full Text] [Related]
8. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
[TBL] [Abstract][Full Text] [Related]
9. Use of Recalled Devices in New Device Authorizations Under the US Food and Drug Administration's 510(k) Pathway and Risk of Subsequent Recalls.
Kadakia KT; Dhruva SS; Caraballo C; Ross JS; Krumholz HM
JAMA; 2023 Jan; 329(2):136-143. PubMed ID: 36625810
[TBL] [Abstract][Full Text] [Related]
10. Assessment of cardiovascular and noncardiovascular medical device recalls.
Somberg JC; McEwen P; Molnar J
Am J Cardiol; 2014 Jun; 113(11):1899-903. PubMed ID: 24837271
[TBL] [Abstract][Full Text] [Related]
11. Medical device recalls and the FDA approval process.
Zuckerman DM; Brown P; Nissen SE
Arch Intern Med; 2011 Jun; 171(11):1006-11. PubMed ID: 21321283
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
13. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
Everhart AO; Sen S; Stern AD; Zhu Y; Karaca-Mandic P
JAMA; 2023 Jan; 329(2):144-156. PubMed ID: 36625811
[TBL] [Abstract][Full Text] [Related]
14. Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety.
Janetos TM; Ghobadi CW; Xu S; Walter JR
Am J Obstet Gynecol; 2017 Jul; 217(1):42-46.e1. PubMed ID: 28500861
[TBL] [Abstract][Full Text] [Related]
15. Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications.
Lee SJ; Cho L; Klang E; Wall J; Rensi S; Glicksberg BS
JAMA Netw Open; 2021 Jun; 4(6):e2112562. PubMed ID: 34156454
[TBL] [Abstract][Full Text] [Related]
16. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
Ronquillo JG; Zuckerman DM
Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
[TBL] [Abstract][Full Text] [Related]
17. Approval-adjusted recall rates of high-risk medical devices from 2002-2016 across food and drug administration device categories.
Ghobadi CW; Janetos TM; Tsai S; Welty L; Walter JR; Xu S
Issues Law Med; 2019; 34(1):77-92. PubMed ID: 31179672
[TBL] [Abstract][Full Text] [Related]
18. US Food and Drug Administration Clearance of Moderate-Risk Otolaryngologic Devices via the 510(k) Process, 1997-2016.
Rathi VK; Gadkaree SK; Ross JS; Kozin ED; Sethi RK; Naunheim MR; Puram SV; Gray ST
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):608-617. PubMed ID: 28786317
[TBL] [Abstract][Full Text] [Related]
19. FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012.
Rome BN; Kramer DB; Kesselheim AS
JAMA; 2014 Jan 22-29; 311(4):385-91. PubMed ID: 24449317
[TBL] [Abstract][Full Text] [Related]
20. Orthopaedic Device Approval Through the Premarket Approval Process: A Financial Feasibility Analysis for a Single Center.
Yang BW; Iorio ML; Day CS
J Bone Joint Surg Am; 2017 Mar; 99(6):e26. PubMed ID: 28291189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
